Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Magrath George. Officer active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 15 disclosures have been published. Breakdown: 4 buys · 3 sells. Total volume traded: €412k. History available since 1 November 2023. The latest transaction was filed on 23 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Magrath George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Magrath George is Chief Executive Officer of Opus Genetics, Inc. and Ocuphire Pharma, Inc. The record shows 9 filings in total, and across the 9 sampled recent filings there were buy transactions totaling 233618 EUR and no sell transactions, with activity dated from 2023-11-03 to 2025-03-26; the modal transaction nature is Attribution.